Marine-Derived Metabolites Act as Promising Antifungal Agents
Marine Drugs · 2024
DOI: 10.3390/md22040180 ↗At a glance
Übersichtsarbeit in Marine Drugs, 2024. Written by Sijin Hang and 2 co-authors. Institution: Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200092 Shanghai, China. Major MEDLINE topics: Antifungal Agents, Aquatic Organisms. Cited 18 times so far (Crossref); 121 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission.
Abstract (original language)
The incidence of invasive fungal diseases (IFDs) is on the rise globally, particularly among immunocompromised patients, leading to significant morbidity and mortality. Current clinical antifungal agents, such as polyenes, azoles, and echinocandins, face increasing resistance from pathogenic fungi. Therefore, there is a pressing need for the development of novel antifungal drugs. Marine-derived secondary metabolites represent valuable resources that are characterized by varied chemical structures and pharmacological activities. While numerous compounds exhibiting promising antifungal activity have been identified, a comprehensive review elucidating their specific underlying mechanisms remains lacking. In this review, we have compiled a summary of antifungal compounds derived from marine organisms, highlighting their diverse mechanisms of action targeting various fungal cellular components, including the cell wall, cell membrane, mitochondria, chromosomes, drug efflux pumps, and several biological processes, including vesicular trafficking and the growth of hyphae and biofilms. This review is helpful for the subsequent development of antifungal drugs due to its summary of the antifungal mechanisms of secondary metabolites from marine organisms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200092 Shanghai, China.
ORCID profiles: Hui Lu
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Innovation Program of Shanghai Municipal Education Commission
Cite
APA
Hang, S., Lu, H., & Jiang, Y. (2024). Marine-Derived Metabolites Act as Promising Antifungal Agents. Marine Drugs. https://doi.org/10.3390/md22040180
Vancouver
Hang S, Lu H, Jiang Y. Marine-Derived Metabolites Act as Promising Antifungal Agents. Marine Drugs. 2024. doi:10.3390/md22040180
BibTeX
@article{Hang2024,
author = {Hang, Sijin and Lu, Hui and Jiang, Yuanying},
title = {Marine-Derived Metabolites Act as Promising Antifungal Agents},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22040180}
}
EUVIMED